Effectiveness of clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic in schizophrenia
This study is completed in the United States. It is testing clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic for schizophrenia.
SchizophreniaBehavioralOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether a digital tool or app may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may use a digital tool or app, attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about whether participation can be remote and what device access is needed, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: January 23, 2025
Recruitment status
Completed
Enrollment listed in the registry
262
Sponsor
Boehringer Ingelheim
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06791122
Official title
A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 31 sites
Sun Valley Behavioral Med Center
Imperial, California
Site status: Not listed — confirm with the team
University of California San Diego
La Jolla, California
Site status: Not listed — confirm with the team
North Country Clinical Research, Inc.
Oceanside, California
Site status: Not listed — confirm with the team
ATP Clinical Research, Inc.
Orange, California
Site status: Not listed — confirm with the team
NRC Research Institute
Orange, California
Site status: Not listed — confirm with the team
Stanford University School of Medicine
Stanford, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Research, LLC
Torrance, California
Site status: Not listed — confirm with the team
CT Clinical Research
Cromwell, Connecticut
Site status: Not listed — confirm with the team
Galiz Research
Hialeah, Florida
Site status: Not listed — confirm with the team
New Life Medical Research Center, Inc.
Hialeah, Florida
Site status: Not listed — confirm with the team
University of Miami
Miami, Florida
Site status: Not listed — confirm with the team
Global Life Research Network
Miami, Florida
Site status: Not listed — confirm with the team
Interventional Psychiatry of Tampa Bay Clinical Research
Tampa, Florida
Site status: Not listed — confirm with the team
Health Synergy Clinical Research, LLC
West Palm Beach, Florida
Site status: Not listed — confirm with the team
Emory University
Atlanta, Georgia
Site status: Not listed — confirm with the team
Sheppard Pratt
Baltimore, Maryland
Site status: Not listed — confirm with the team
CBH Health, LLC
Gaithersburg, Maryland
Site status: Not listed — confirm with the team
Boston Neurobehavioral Associates
Brookline, Massachusetts
Site status: Not listed — confirm with the team
UMass Chan Medical School
Worcester, Massachusetts
Site status: Not listed — confirm with the team
Western Michigan University Homer Stryker M.D. School of Medicine
Kalamazoo, Michigan
Site status: Not listed — confirm with the team
St. Charles Psychiatric Associates - Midwest Research Group
Saint Charles, Missouri
Site status: Not listed — confirm with the team
IMA Clinical Research Las Vegas
Las Vegas, Nevada
Site status: Not listed — confirm with the team
Neurobehavioral Research, Inc.
Cedarhurst, New York
Site status: Not listed — confirm with the team
Richmond Behavioral Associates
Staten Island, New York
Site status: Not listed — confirm with the team
Atrium Health Behavioral Health Digital Therapy
Charlotte, North Carolina
Site status: Not listed — confirm with the team
Rivus Wellness and Research Institute
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Psychiatric Consultants, PC
Franklin, Tennessee
Site status: Not listed — confirm with the team
Beaumont Psychiatry Clinic
Beaumont, Texas
Site status: Not listed — confirm with the team
Red Oak Psychiatry Associates, PA
Houston, Texas
Site status: Not listed — confirm with the team
SMS Clinical Research, LLC
Mesquite, Texas
Site status: Not listed — confirm with the team
Salem VA Medical Center
Salem, Virginia
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06791122. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring digital app or tool for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study involving Digital therapeutic (CT-155). Phase is mainly useful to check for medication studies and some device studies.
Who might this study be for?
This study may concern people with schizophrenia; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
